Capecitabine Plus Bevacizumab as First-Line Therapy for Patients with Metastatic Colorectal Cancer and Poor Performance Status.
| Autor: | Yasufumi Yamada1 yamadayasu_0129@me.com, Kazuhiko Yoshimatsu1, Hajime Yokomizo1, Sachiyo Okayama1, Masaya Satake1, Arika Ida1, Hiroyuki Maeda1, Shunichi Shiozawa1 |
|---|---|
| Zdroj: | Journal of Nippon Medical School. 2021, Vol. 88 Issue 5, p496-499. 4p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|